Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001410578-23-000575
Filing Date
2023-03-31
Accepted
2023-03-31 17:00:51
Documents
99
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tmb-20221231x10k.htm   iXBRL 10-K 2459202
2 EX-23.1 tmb-20221231xex23d1.htm EX-23.1 3260
3 EX-31.1 tmb-20221231xex31d1.htm EX-31.1 11171
4 EX-31.2 tmb-20221231xex31d2.htm EX-31.2 12156
5 EX-32 tmb-20221231xex32.htm EX-32 9258
  Complete submission text file 0001410578-23-000575.txt   9679406

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20221231.xsd EX-101.SCH 85909
7 EX-101.CAL tmb-20221231_cal.xml EX-101.CAL 58773
8 EX-101.DEF tmb-20221231_def.xml EX-101.DEF 225319
9 EX-101.LAB tmb-20221231_lab.xml EX-101.LAB 635236
10 EX-101.PRE tmb-20221231_pre.xml EX-101.PRE 463999
93 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20221231x10k_htm.xml XML 1557275
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005
Petros Pharmaceuticals, Inc. (Filer) CIK: 0001815903 (see all company filings)

EIN.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39752 | Film No.: 23788928
SIC: 2834 Pharmaceutical Preparations